We have investigated the switch regions of Ig heavy chain genes of patients with IgA glomerulonephritis (IgA-GN) using restriction fragment length polymorphism (RFLP) analysis.
Introduction
In many countries IgA glomerulonephritis (IgA-GN)' is the most common form of glomerulonephritis, accounting for 20-30% of biopsy-confirmed cases according to the country in which the study was performed (1) . Several clinical observations point to a genetic predisposition being important in its pathogenesis. First, IgA-GN may be familial (2) and it also occurs in siblings (3) . Second, IgA-GN is associated with inherited complement defects and Ig kappa light chain allotypes (4, 5) . Finally, subtle immunological abnormalities have been recognized in healthy relatives of patients with IgA-GN, including the presence of cold-reacting anti-nuclear factor and IgA bearing peripheral blood lymphocytes (6, 7). 1 . Abbreviations used in this paper: GN, glomerulonephritis; RFLP, restriction fragment length polymorphism; Sal, Ig Cal switch region; SM, Ig CM switch region; SSC, standard saline citrate.
The circumstantial evidence for immunogenetic factors prompted us to examine Ig heavy chain switch region polymorphism in patients with IgA-GN. The switch regions of Ig heavy chain genes are highly repetitive sequences and mediate the Ig isotype switch, for instance from IgM to IgG. They occur on the 5' side of all functional Ig constant heavy chain genes except Ce. The repetitive nature ofthe switch sequences means that cross-hybridization occurs when a switch region probe is used. Hence a DNA probe homologous to the Ig Cu switch region (S,), when used in conjunction with Sst I restriction endonuclease, can detect restriction fragment length polymorphism (RFLP) in Stt and also the switch region flanking the Ig CalI gene (Sal) (8) ; other switch regions are also detected but the polymorphisms occur at a very low frequency (8) . A total of six independent loci can be identified, five of which are in strong linkage disequilibrium. They give rise to 28 different haplotypes that segregate in a Mendelian fashion. Therefore a large portion of the Ig constant heavy chain gene loci can be investigated using one probe. Using a similar S,u probe, this DNA region has recently been shown to be associated with other forms of immunologically mediated renal disease, including membranous nephropathy (9, 10 The frequency ofthe putative heplotypes is shown in Table  III . The frequency ofthe 2.1 ;6.9-kb haplotype was significantly decreased in the patient group (0.1 vs. 0.213 in controls, P = 0.01). There was a compensatory increase in the frequency of the 2.6;7.4-and 2.1 ;7.4-kb haplotypes (P = 0.04 and 0.07, respectively).
Hardy-Weinberg analysis showed that in caucasoids of West-and Mid-European origins the SMA and Sal alleles examined comprised > 99.3% of all possible alleles. There is a suggestion that in uremia artefactual RFLPs may appear (14) . However, none of the patients studied was uremic, and no fragments of unusual electrophoretic mobility were noted, though two control samples did have bands of unusual mobility.
Discussion
The consequences of polymorphism in Ig heavy chain switch region for Ig function have not been defined in humans. By analogy with data in the mouse (15) it is likely, however, that differences in switch region sequences are associated with alterations in immune repertoire expression. Since switch region polymorphism may be associated with differences of the variable heavy chain region genes, it is conceivable that altered SMu and Sa 1 genotypes and phenotypes are secondary to restrictions in the antigen recognition repertoire. In a recent study, plasma from patients with mesangial IgA-GN, but not controls, interacted with a glomerular basement membrane epitope, a finding also consistent with restriction of the recognition mechanism (16) . Similar considerations apply to the recent recognition of polymorphism of the Ig heavy chain switch region in other histological types ofglomerulonephritis (9) . On the other hand, the association with switch region polymorphisms may be related to the constant region via a feature of the expressed product, for example isoelectric point and ability to activate complement. In this context it is of note that in patients with mesangial IgA-GN, elution of IgA deposited in the glomerulus revealed pl restriction ( 17) . Although the frequency of the SM alleles is not significantly different in IgA-GN, the SM phenotypes are not in HardyWeinberg equilibrium, as there is a significant reduction in the number of SM heterozygotes. This suggests that they are resistant to the development of the disease. In contrast, at the Sal locus the 7.4-kb allele and the 7.4-kb phenotype are associated with IgA-GN, indicating that the Sal allele may be a risk factor for susceptibility to IgA-GN. These results suggest that there may be two separate associations of IgA-GN with Ig switch regions, one with SM and the other with Sal. At the moment it is unclear if these markers are present on the same chromosome or two different ones. Analysis of the haplotypes suggests that both the 2.6;7.4-and the 2.1;7.4-kb haplotypes are increased in IgA-GN, with a decreased frequency of the 2.1;6.9-kb haplotype. Further studies using multiply affected families may help to resolve this.
The magnitude of change in switch region allele frequencies and phenotype frequencies is such that our observation has currently no diagnostic value. However, in other immune diseases it can be shown that simultaneous consideration of different markers, even when coded on different chromosomes, increases the relative risk ofdisease. One example is the connection between Ig switch region, T cell receptor, and HLA phenotypes in myasthenia gravis (18) . In view of the known association of mesangial IgA-GN with genetic abnormalities of complement factors; allotypes of complement factors C3, factor B, and Ig kappa light chain (4, 5) ; and the inconsistent evidence of an association with HLA-B and HLA-DR (19) , the findings reported here may gain substantial importance in association with other disease markers.
